CA2675122A1 - Method for detection of human immunodeficiency virus - Google Patents

Method for detection of human immunodeficiency virus Download PDF

Info

Publication number
CA2675122A1
CA2675122A1 CA002675122A CA2675122A CA2675122A1 CA 2675122 A1 CA2675122 A1 CA 2675122A1 CA 002675122 A CA002675122 A CA 002675122A CA 2675122 A CA2675122 A CA 2675122A CA 2675122 A1 CA2675122 A1 CA 2675122A1
Authority
CA
Canada
Prior art keywords
seq
bioengineered
high affinity
antigen
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002675122A
Other languages
English (en)
French (fr)
Inventor
Kalle Saksela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Next Biomed Technologies NBT Oy
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2675122A1 publication Critical patent/CA2675122A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C07K16/1143—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/161—HIV-1, HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002675122A 2007-01-17 2008-01-17 Method for detection of human immunodeficiency virus Abandoned CA2675122A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88535207P 2007-01-17 2007-01-17
FI20075028A FI120376B (fi) 2007-01-17 2007-01-17 Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi
FI20075028 2007-01-17
US60/885,352 2007-01-17
PCT/FI2008/050012 WO2008087254A2 (en) 2007-01-17 2008-01-17 Method for detection of human immunodeficiency virus

Publications (1)

Publication Number Publication Date
CA2675122A1 true CA2675122A1 (en) 2008-07-24

Family

ID=37745720

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002675122A Abandoned CA2675122A1 (en) 2007-01-17 2008-01-17 Method for detection of human immunodeficiency virus

Country Status (8)

Country Link
US (1) US20100048407A1 (cg-RX-API-DMAC7.html)
EP (1) EP2109772A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010516660A (cg-RX-API-DMAC7.html)
CN (1) CN101646944A (cg-RX-API-DMAC7.html)
AU (1) AU2008206881A1 (cg-RX-API-DMAC7.html)
CA (1) CA2675122A1 (cg-RX-API-DMAC7.html)
FI (1) FI120376B (cg-RX-API-DMAC7.html)
WO (1) WO2008087254A2 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO314588B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
US6818392B2 (en) * 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US6833441B2 (en) * 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers

Also Published As

Publication number Publication date
US20100048407A1 (en) 2010-02-25
WO2008087254A8 (en) 2009-07-30
FI20075028L (fi) 2008-07-18
EP2109772A4 (en) 2010-09-29
CN101646944A (zh) 2010-02-10
FI120376B (fi) 2009-09-30
JP2010516660A (ja) 2010-05-20
WO2008087254A2 (en) 2008-07-24
AU2008206881A1 (en) 2008-07-24
FI20075028A0 (fi) 2007-01-17
EP2109772A1 (en) 2009-10-21

Similar Documents

Publication Publication Date Title
Juno et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
CN107022027B (zh) Hiv-1广谱中和抗体及其用途
CN104520318B (zh) 针对jc病毒的vp1蛋白的人单克隆抗体
PT1881064E (pt) Anticorpo monoclonal anti-núcleo de hcv
Chen et al. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1
Buffington et al. Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2
US8735328B2 (en) Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
US20100048407A1 (en) Method for detection of human immunodeficiency virus
TWI886305B (zh) 抗人類免疫缺陷病毒-１抗體、包含其的細胞、核酸、組合物及套組
Liu et al. Bispecific monoclonal antibodies against a viral and an enzyme: utilities in ultrasensitive virus ELISA and phage display technology
US8809004B2 (en) Detection of feline immunodeficiency virus
JPH04505621A (ja) Ｔリンパ球向性レトロウイルス単クローン抗体
Zhang et al. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors
Makdasi et al. Neutralizing monoclonal anti‐SARS‐CoV‐2 antibodies isolated from immunized rabbits define novel vulnerable spike‐protein epitope. Viruses. 2021; 13 (4): 566
de Marco Isolation of recombinant antibodies that recognize native and accessible membrane biomarkers
Twair et al. Production of polyclonal antibody against M13 phage for application in nanobody technology
Burciaga-Flores et al. A New Approach in DENV Diagnostic based on Linear Peptides Obtained by Phage Display
Altman et al. HIV envelope trimers and gp120 as immunogens to induce broadly neutralizing antibodies in cows
Lai Focusing Vaccine Antibody Responses on Vulnerable Viral Epitopes
CN118063602A (zh) 一种从shiv攻毒的恒河猴体内分离的v3特异性广谱中和抗体
CN114437205A (zh) 抗冠状病毒抗体及其应用
CN119462912A (zh) 抗埃博拉病毒vp40蛋白的纳米抗体及在病毒检测中的应用
Chen et al. Isolation of human antibodies against hepatitis E virus from phage display library by immobilized metal affinity chromatography
CN115960215A (zh) 一种抗hiv的抗体
CN121270690A (zh) 一株绵羊抗蓝舌病毒vp7蛋白的重组单克隆抗体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20160119

FZDE Discontinued

Effective date: 20160119